Published TCIMAIL newest issue No.199
Maximum quantity allowed is 999
Bitte wählen Sie die Menge aus.
Glycogen Synthase Kinase (GSK) Inhibitor
No.164(January 2015)
(2'Z,3'E)-6-Bromoindirubin-3'-oxime (BIO, 1) is a cell-permeable indirubin compound and acts as an inhibitor of glycogen synthase kinase-3 (GSK-3).1,2) As shown below, the inhibitory activity of 1 is highly selective to GSK-3 in comparison with other kinases.1)
Inhibition of GSK by 1 mediates the activation of the Wnt signaling pathway and sustains pluripotency in human and mouse embryonic stem (ES) cells.3) 1 is also reported to induce the differentiation of neonatal cardiomyocytes and to maintain self-renewal in human and mouse ES cells.4)
References
- 1)GSK-3-selective inhibitors derived from Tyrian purple indirubins
- 2)Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases
- 3)Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor
- 4)The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.